Okt3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation

Daniel Portela, Robin Patel, Jeffrey J. Larson-Keller, Duane M. Ilstrup, Russell H. Wiesner, Jeffery L. Steers, Ruud A.F. Krom, Carlos V. Paya

Research output: Contribution to journalArticlepeer-review

115 Scopus citations

Fingerprint

Dive into the research topics of 'Okt3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences